Feb 17, 2021 01:35 PM IST
Apart from Bharat Biotech’s Covaxin, Pune-based Serum Institute of India (SII) had collaborated with AstraZeneca and the University of Oxford and developed Covishield. This vaccine has been granted emergency approval in India. Let’s take a look at India’s vaccine diplomacy in various countries.
- Jan 23, 2021 03:35 PM IST
The palm-fringed Pune campus, whose grounds boast horse-shaped topiaries in a playful nod to the firm's origins, is home to several buildings where vaccines are manufactured and scrutinised for quality before being deposited into sterilised vials and stored for delivery.
- Jan 21, 2021 08:30 PM IST
Maharashtra Chief Minister Uddhav Thackeray will visit Serum Institute of India's facility in Pune on January 22 to take stock of the situation.
- Jan 16, 2021 01:12 PM IST
India has started its COVID-19 vaccination drive. Here's a look at the two vaccines that have been approved for restricted emergency use, and answers to all your questions about the jabs, the registration process and more
- Jan 06, 2021 07:22 PM IST
Drug General Controller of India (DGCI) has approved the Oxford COVID-19 vaccine Covishield, manufactured by Serum Institute of India (SII) and Covaxin of Bharat Biotech for restricted emergency use in the country. From registration to the vaccination process, here are all your questions about the Covid-19 vaccination drive answered.